A model displays Sony Corp (ADR) (NYSE:SNE) newly introduced game machine, the PlayStation Portable (PSP), at the Sony booth during the Tokyo Game Show on September 24, 2004 in Makuhari, Chiba Prefecture, Japan. Sony Corp. will stop selling this hand-held video game by the end of this year. Sony Corp (ADR) (NYSE:SNE) net profit margin is -1.60% and weekly performance is -3.37%. On last trading day company shares ended up $16.08. Analysts mean target price for the company is $21.51. Sony Corp (ADR) (NYSE:SNE) distance from 50-day simple moving average is -9.41%.
The Advanced Micro Devices, Inc. (NYSE:AMD) on June 2 announced that it has agreed to sell $500 million aggregate principal amount of its 7.00% Senior Notes due 2024 in a private offering. AMD intends to close the transaction on or around June 16, 2014.Advanced Micro Devices, Inc. (NYSE:AMD) shares fell -0.76% in last trading session and ended the day on $3.94. AMD Gross Margin is 36.00% and its return on assets is 1.00%. Advanced Micro Devices, Inc. (NYSE:AMD) quarterly performance is 6.49%.
NVIDIA Corporation (NASDAQ:NVDA)‘s GTX Titan Z graphics card is finally available after being revealed back in March at the CDG 2014. The GTX Titan Z is said to be the most powerful graphics card in the world and comes at an equivalently high price. NVIDIA Corporation (NASDAQ:NVDA) shares moved down -0.42% in last trading session and was closed at $18.86, while trading in range of $18.61-$19.00. NVIDIA Corporation (NASDAQ:NVDA) year to date performance is 18.84%.
Deutsche Bank reissued their hold rating on shares of ARM Holdings plc (NASDAQ:ARMH) in a research report released on Wednesday morning.ARM Holdings plc (ADR) (NASDAQ:ARMH) ended the last trading day at $45.81. Company weekly volatility is calculated as 1.39% and price to cash ratio as 22.09. ARM Holdings plc (ADR) (NASDAQ:ARMH) showed a negative weekly performance of -1.76%.
Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (OTCBB:SPRWF)(CSE:SL) is pleased to report that the Company has closed the previously announced arms-length acquisition of a Southern Ontario based company (the “Target Company”) that holds a pre-build Marijuana for Medical Purposes Regulations licence (“MMPR Licence”). Under the terms of the MMPR Licence, the Target Company can build out and operate the recently purchased 342,000 square foot facility capable of producing up to 24,000,000 grams (24,000 kilograms) of medicinal marijuana per year. SUPREME PHARMACEUTIC (OTCMKTS:SPRWF) On last trading day company shares ended up $0.0800.